Using human colon carcinoma HCT116 cells, Menendez et al. found that ERβ bound to a ligand and acting in cis is required or can stimulate the function of selected P53 mutants toward at least some half and full site response elements and also an endogenous gene target [55]. The gene discussed is ESR2; the disease is colon carcinoma.